Issue Archive
|
Subscribe
|
Editorial Board
|
About
|
Contact
|
Advertise
Home
News
Daily Nephrology News
Daily Urology News
FDA News
Malpractice News
Industry News
Newsletters
Polls & Surveys
Top 10 2008 Stories
Urology
Bladder Cancer
Benign Prostatic Hyperplasia
Erectile Dysfunction
Kidney Cancer
Kidney Stones
Overactive Bladder
Premature Ejaculation
Prostate Cancer
Prostate Specific Antigen
Reproductive Medicine
Urinary Incontinence
Urinary Tract Infections
Nephrology
Acute Kidney Injury
Acute Renal Failure
Anemia
Chronic Kidney Disease
Contrast Nephropathy
Cardiovascular Disease
Diabetes
Diabetic Nephropathy
Focal Segmental Glomerulosclerosis
Hemodialysis
Hyperphosphatemia
Hypertension
Kidney Cancer
Kidney Stones
Lupus Nephritis
Peritoneal Dialysis
Secondary Hyperparathyroidism
Transplantation
Clinical Trials
Acute Kidney Injury
Bladder Cancer
Diabetes Mellitus
Hemodialysis
Hyperphosphatemia
Kidney/Ureteral Stones
Lupus Nephritis
Nephrogenic Systemic Fibrosis
Overactive Bladder
Pelvic Prolapse
Prostate Cancer
Renal Cell Carcinoma
Renal Obstruction
Renal Transplant
Voiding Dysfunction
Commentary
Conferences
Conference Highlights
Meetings Calendar
Renal Week 2008
29th Annual Dialysis Conference
EAU Conference 2009
NKF Spring Meetings
AUA Annual Meeting
ASH Annual Meeting
American Transplant Congress 2009
Canadian Urological Association Annual Meeting
Renal Week 2009
Genitourinary Cancers Symposium
Expert Series
Jobs
Resources
Links
View Full Issue
Features
Cleveland Clinic
World Lit. Review
Legal Issues
Renal Nutrition Update
Your Money
Your Practice
Drug Info
myCME
RSS
|
Login
|
Register
Home
>
Nephrology
> Contrast Nephropathy
Contrast Nephropathy
High Incidence of Contrast-Induced Nephropathy Found
Jody A. Charnow
January 15, 2010
Contrast-induced nephropathy (CIN) develops in 11% of emergency department patients who undergo contrast-enhanced CT (CECT), according to a study published in the Clinical Journal of the American Society of Nephrology (2009; published online ahead of print).
Sodium Bicarbonate Does Not Decrease CIN Risk
Jody A. Charnow
October 16, 2009
A recent study shows that sodium bicarbonate is no better than saline in preventing contrast-induced nephropathy (CIN).
CIN May Have a Causal Role in Long-Term Adverse Events
Jody A. Charnow
July 23, 2009
Evidence comes from a study comparing two strategies for preventing contrast-induced nephropathy
CIN Prevention Remains a Challenge
Sankar D. Navaneethan, MD, MPH
April 07, 2009
Contrast-induced nephropathy (CIN), defined as a rise in serum creatinine greater than 0.5 mg/dL or a level greater than 25% from baseline following use of intravascular contrast media, is increasing.
Trial for Fluid Replacement System and CIN Prevention
William Weber
January 22, 2009
PLC Medical Systems, Inc., of Franklin, Mass., has received full approval for a U.S. pivotal trial to study the effectiveness of its RenalGuard System and associated therapy in the prevention of contrast-induced nephropathy (CIN).
CIN Risk Similar With Iso- and Low-Osmolar Contrast
Alice Goodman
July 21, 2008
CHICAGO—Iso-osmolar and low-osmolar contrast agents showed similar nephrotoxicity in a study of patients with impaired renal function undergoing percutaneous coronary intervention (PCI), according to findings presented here at the American College of Cardiology annual meeting.
CIN Rare After Chest Imaging Procedures
Alice Goodman
July 21, 2008
CHICAGO—Routine use of contrast agents for evaluating chest pain carries a risk of contrast- induced nephropathy (CIN).
Targeted Renal Therapy May Stop CIN
John Schieszer
July 15, 2008
WASHINGTON, D.C.—Targeted renal therapy (TRT) involving intrarenal administration of fenoldopam is safe and feasible in patients undergoing angiographic procedures, even in patients at elevated risk of suffering from contrast-induced nephropathy (CIN).
N -Acetylcysteine is Renoprotective
Jody A. Charnow
May 05, 2008
A RECENT meta-analysis supports administration of N-acetylcysteine prophylaxis to prevent contrast-induced nephropathy, especially in high-risk patients. Researchers also noted that the drug is inexpensive and readily available, and has few side effects.
Pivotal Study Okayed for Nephropathy Prevention Device
William Weber
May 01, 2008
PLC Systems Inc., of Franklin, Mass., has received conditional approval to begin enrollment in a pivotal trial to study the effectiveness of its RenalGuard Therapy and RenalGuard System in the prevention of contrast-induced nephropathy (CIN).
more »
NKF Live
Sign up for the NKF Live e-newsletter to receive daily news coverage of the National Kidney Foundation 2010 Spring Clinical Meetings in Orlando, Fla.
Click here to sign up today
Visit Fresenius Medical Care during the National Kidney Foundation 2010 Spring Clinical Meetings in Orlando, Fla. at Booth #407.
Visit our
Conference Highlights
section for news from recent meetings, including our coverage of the 2010 Genitourinary Cancers Symposium.
Visit
Your Practice
for articles relating to the everyday business of nephrologists and urologists.
Renal & Urology News
E-Newsletters
Sign up today
to start receiving one of three free e-newsletters from Renal & Urology News or get them all.
- eTOC (print edition preview)
- RUN Roundup
- Conference Highlights
Sample
|
Subscribe
|
Archive
Renal Nutrition Update
For the latest nutrition news and studies,
click here
to visit our Renal Nutrition Update dept.
Our
World Literature Review
department has information on the latest nephrology and urology studies from around the world.
Most Popular
Most Emailed
Most Recent
Dietary Fat and Prostate Cancer Risk
Glycemic Control in Diabetic ESRD Patients
DASH Diet Variation May Help Lower Blood Pressure
Live Kidney Donation Does Not Shorten Survival
Chemo May Improve Survival in Men with Advanced PCa on ADT
A doctor referred a man with an elevated PSA level to a urologist, but did not follow-up and ask him if he went
Use of Kidneys From High-Risk Donors Drops
Clinical Trial: A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis
Clinical Trial: Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD) (SIR)
Clinical Trial: Immune System Related Kidney Disease
Drinking Alcohol Raises Prostate Cancer Risk in African Americans
Live Kidney Donation Does Not Shorten Survival
Prostate Cancer Deaths Uncommon Even 30 Years After Surgery
Dietary Fat and Prostate Cancer Risk
Hypogonadism Linked to Statin Use
Novel Drug Prolongs Survival in Men with Metastatic Prostate Cancer
Relief for Haiti's ESRD Patients
Start-Stop Hormone Therapy For Prostate Cancer May Have Benefits
DASH Diet Variation May Help Lower Blood Pressure
Urine Test Accurately Predicts Significant Prostate Cancer
Clinical Trial: Bowel Preparation and Pelvic Organ Prolapse Surgery
Clinical Trial: Pelvic Floor Repair Systems for Prolapse Repair (PROPEL)
Clinical Trial: Comparison of Burch Urethropexy and Mid-urethral Sling Performed Concomitantly With a Sacral Colpopexy
Clinical Trial: Local Anesthetic Treatments for Overactive Bladder
Clinical Trial: Pilot Study: Is Overactive Bladder Caused by Subacute Urinary Tract Infections?
Clinical Trial: Caffeine Reduction and Overactive Bladder Symptoms
Clinical Trial: Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years
Robotic Pyeloplasty Has Advantages
Clinical Trial: Nephrogenic Systemic Fibrosis (NSF): A Chart Review With Analysis of Tissue Gadolinium Levels
Clinical Trial: Immune System Related Kidney Disease
Popular Topics
Acute Kidney Injury
Adrenal Gland
Brachytherapy
Cardiovascular Disease
Chronic Kidney Disease
CKD
Diabetes
End-stage Renal Disease
FSGS
Hemodialysis
Hypertension
Infection
Kidney Cancer
Kidney Disease
Nutrition
Obesity
Prostate Cancer
Prostatitis
PSA
Renal Cell Carcinoma
Renal Masses
Transplantation
Urologic Surgery
Urology
UTI
Sponsored Links